William Anderson Wittekind - 11 Apr 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
10%+ Owner
Signature
/s/ William Anderson Wittekind
Issuer symbol
RENB
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
4
Filing time
06 Feb 2023, 18:29:37 UTC
Previous filing
06 Feb 2023
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Other +97,032 +2% 5,058,395 11 Apr 2022 Weird Science LLC F1, F2
holding RENB Common Stock 2,711,605 11 Apr 2022 Direct F3
holding RENB Common Stock 1,500,568 11 Apr 2022 GRATs F4
holding RENB Common Stock 9,462,554 11 Apr 2022 Spouse F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement.
F2 The Reporting Person is a manager of Weird Science LLC.
F3 Includes 88,121 shares held by the Reporting Person and his spouse as joint tenants with a right of survivorship (JTWROS).
F4 Shares held by certain grantor retained annuity trusts (GRATs) of which the Reporting Person is the sole trustee.
F5 Excludes 88,121 shares held with the Reporting Person as JTWROS. Such shares are included in the Reporting Person's direct beneficial ownership as described in note 3 above.
F6 The Reporting Person disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuniary interest therein, and for any other purpose.